Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to earnings of $0.65 per share a year ago. These figures are adjusted for non-recurring items.Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to earnings of $0.65 per share a year ago. These figures are adjusted for non-recurring items.Read MoreStocks,InvestingStocks Feed